UCI stem cell therapy attacks cancer by targeting unique tissue stiffness
Study shows success in stamping out deadly metastatic cells
Study shows success in stamping out deadly metastatic cells
Sue & Bill Gross Stem Cell Research Center researchers have reported that a therapy they created to cure retinitis pigmentosa is safe and well-tolerated, with no immunological issues, by the first group of patients enrolled in an ongoing phase I/II clinical trial. Led by the regenerative medicine company jCyte, the trial has successfully undergone four […]
Microvesicle injections restored cognition without adverse side effects
UCI mouse study finds significant improvements in both motor and cognitive function
Dr. Henry Klassen’s stem cell-based treatment to repair the retina is now in a clinical trial, offering new hope for people suffering from retinitis pigmentosa
Participants are sought for safety study on the use of retinal progenitors in the eye
CIRM funding will support effort to advance therapy into clinical trials
UCI study reveals how they alleviate ‘chemobrain’ after cancer treatments
A UCI stem cell researcher will receive a $1.15 million CIRM grant to advance the study of brain immune cells and their role in Alzheimer’s disease.
In a first-of-its-kind alliance, UC Irvine’s Sue & Bill Gross Stem Cell Research Center and UCLA’s Eli & Edythe Broad Center of Regenerative Medicine & Stem Cell Research have received a five-year, $8 million grant from the California Institute of Regenerative Medicine to establish a CIRM Alpha Stem Cell Clinic.